14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
JRS vs NRO: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
JRS Overall Winner
6-Pillar Tally: JRS 1 – 0 NRO (5 Tie)
Matrix Metrics: JRS 3 – 1 NRO
As of Nov 16, 2026, Nuveen Real Estate Income Fund (JRS) is the stronger overall head-to-head candidate over Neuberger Berman Real Estate Sec. Income Fund Inc. (NRO) in the Tradestie Institutional Equity Comparison Engine, winning 3–1 core matrix metrics and 1–0 across our 6-pillar institutional scorecard (led by Growth & Scale). JRS carries a Unified Composite Score of 41.9/100 (SELL) at $7.59 (N/M Forward P/E, N/A operating margin), whereas NRO carries 46.2/100 (HOLD) at $2.61 (N/M Forward P/E, N/A operating margin).
Composite vs. Pillar Nuance: While NRO currently prints a higher short-term Unified Composite Score (46.2/100 HOLD vs. JRS 41.9/100 SELL), JRS captures the overall institutional head-to-head verdict (3–1 matrix metrics and 1–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY).
Technical & Structure Timing Caution: JRS trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 52.1); meanwhile NRO is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 46.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on JRS vs NRO. Trailing 12-month operating profitability (JRS N/A vs NRO N/A) and valuation multiples (JRS N/M vs NRO N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with $236.9M market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
NRO Moat ProfileCyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with $205.9M market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ JRS vs NRO Key Questions & Quantitative Answers
As of Nov 16, 2026, Nuveen Real Estate Income Fund (JRS) is the stronger overall head-to-head candidate over Neuberger Berman Real Estate Sec. Income Fund Inc. (NRO) in the Tradestie Institutional Equity Comparison Engine, winning 3–1 core matrix metrics and 1–0 across our 6-pillar institutional scorecard (led by Growth & Scale). JRS carries a Unified Composite Score of 41.9/100 (SELL) at $7.59 (N/M Forward P/E, N/A operating margin), whereas NRO carries 46.2/100 (HOLD) at $2.61 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While NRO currently prints a higher short-term Unified Composite Score (46.2/100 HOLD vs. JRS 41.9/100 SELL), JRS captures the overall institutional head-to-head verdict (3–1 matrix metrics and 1–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY). Technical & Structure Timing Caution: JRS trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 52.1); meanwhile NRO is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 46.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
JRS leads the Growth & Scale pillar: JRS posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with NRO at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, JRS generates N/A in USD-normalized revenue versus N/A for NRO. In operating R&D and SG&A reinvestment, JRS deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for NRO.
JRS and NRO trade at balanced relative valuation multiples. JRS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas NRO trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against JRS (N/A ROE) versus NRO (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, JRS carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.48β · 19% Vol realized risk). By comparison, NRO carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.42β · 22% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.